Desulphation of heparin by mice and guinea pig leukocytes

Insights

Mouse macrophages possess significant heparin-degrading capabilities, influencing its anticoagulant properties. Spleen extracts can neutralize heparin

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Heparin is a widely used anticoagulant.
  • The enzymatic degradation of heparin is not fully understood.
  • Leukocytes are immune cells with diverse enzymatic functions.

Purpose of the Study:

  • To investigate the sulphate-splitting activity of leukocytes on heparin.
  • To determine which leukocyte types exhibit heparin-degrading activity.
  • To assess the effect of spleen extracts on heparin's anticoagulant function.

Main Methods:

  • Incubation of heparin with leukocytes (macrophages, neutrophils, lymphocytes) from mice and guinea pigs.
  • Measurement of released sulphate as an indicator of heparin degradation.
  • Maintenance of mouse macrophages in tissue culture to study long-term degradation.
  • Testing the effect of spleen extracts on heparin's anticoagulatory activity.

Main Results:

  • Mouse macrophages demonstrated the highest heparin sulphate-splitting activity.
  • Mouse neutrophils and lymphocytes exhibited weak heparin-degrading activity.
  • Degradation of heparin by cultured mouse macrophages increased with incubation time up to 96 hours.
  • Spleen extracts effectively neutralized heparin's anticoagulant effects.

Conclusions:

  • Macrophages are key players in heparin degradation.
  • Heparin degradation by macrophages is a time-dependent process.
  • Spleen extracts possess components that can counteract heparin's anticoagulant action.